A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes

This study has been completed.

Sponsor:

Collaborator:

Amylin Pharmaceuticals, LLC.

Information provided by (Responsible Party):

David M. Huffman MD, University Diabetes & Endocrine Consultants

ClinicalTrials.gov Identifier:

NCT00502138

First received: July 16, 2007

Last updated: January 15, 2013

Last verified: January 2013

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)

No publications provided by University Diabetes & Endocrine Consultants

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Huffman DM, McLean GW, Seagrove MA. Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study. Endocr Pract. 2009 Nov-Dec;15(7):689-95.

To Top